About Aimil Pharmaceuticals(India) Limited
Data last updated:
Aimil Pharmaceuticals(India) Limited is a public limited company based in New Delhi, Delhi, India. It operates in the ayurvedic products and services segment of the healthcare sector. It was incorporated on 30 November 1984 and has been in existence for over 42 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24231DL1984PLC019461. Its GSTIN is 07AAACA6166G1ZT (Delhi). The company holds 24 GST registrations, of which 20 are active.
The company has an authorised share capital of ₹14.5 Cr and a paid-up capital of ₹11.55 Cr. It was formerly known as Aimil Pharmaceuticals India Private Limited. It is led by directors including Kanwal Kumar Sharma (Managing Director) and Ikshit Sharma.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at 2994/4 Street No 17 Ranjeet Nagar, New Delhi, Delhi, India – 110008.
As per the financials filed for FY 2023, the company reported a revenue of ₹480.65 Cr, a growth of 7% compared to the previous year. For the same year it recorded a net profit of ₹5.01 Cr (net margin 1%) and EBITDA of ₹25.92 Cr (EBITDA margin 5.4%). Revenue has grown at a compounded annual rate (CAGR) of 18% over three years and 11% over five years.
The company has about 195 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Aimil Pharmaceuticals. As per MCA filings, the company has open charges of ₹94.34 Cr and satisfied charges of ₹24 Cr on record. Court records list 105 cases involving the company, including 53 filed by the company and 52 filed against it; 20 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website aimilpharmaceuticals.com.
Company details
Contact details
Aimil Pharmaceuticals(India) Limited's registered office is in New Delhi, Delhi. Its website is aimilpharmaceuticals.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address2994/4 Street No 17 Ranjeet Nagar, New Delhi, Delhi, India – 110008
- IndustryHealthcare, Ayurvedic Products & Services
To see the full contact details of Aimil Pharmaceuticals(India) Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Aimil Pharmaceuticals(India) operates one associated brand: Aimil Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Ayurvedic pharmaceutical products and natural healthcare solutions in India. | aimilpharmaceuticals.com |
Business activity
The main business activity of Aimil Pharmaceuticals(India) is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Aimil Pharmaceuticals(India) Limited, buy the company report.
Financials of Aimil Pharmaceuticals(India) Limited
FY 2023 filings availableAimil Pharmaceuticals(India) Limited reported revenue of ₹480.65 Cr (up 7% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 11% over five years, including 7% growth in the latest year. EBITDA rose 20% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹480.65 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹25.92 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹5.01 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.4% | ||||
| Net Profit Margin | 1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Aimil Pharmaceuticals(India) Limited, buy the company report.
Board of directors of Aimil Pharmaceuticals(India) Limited
Aimil Pharmaceuticals(India) has 6 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ikshit Sharma | Director | 21 Nov 2019 | 6 Years 11 Months | Current |
| Sanchit Sharma | Additional Director | 12 Feb 2025 | 1 Years 8 Months | Current |
| Kanwal Kumar Sharma | Managing Director | 30 Nov 1984 | 41 Years 11 Months | Current |
| Pankaj Marwaha | Director | 26 Sep 1988 | 38 Years 1 Months | Current |
| Satya Prakash Shrivastava | Director | 18 Aug 2014 | 12 Years 2 Months | Current |
| Manjula Sharma Also directs: Aimil India Research Foundation | Director | 24 Jul 1996 | 30 Years 3 Months | Current |
Peer comparison
Aimil Pharmaceuticals(India) Limited is compared with the 4 companies closest to it by revenue in the Healthcare industry (Ayurvedic Products and Services), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Siddhayu Ayurvedic Research Foundation Pvt Ltd | ₹609.38 Cr (FY 2023) | 31.0% | Mumbai, Maharashtra, India | |||
| Natural Remedies Private Limited | ₹548.65 Cr (FY 2025) | 11.0% | Bangalore, Karnataka, India | |||
| Aimil Pharmaceuticals(India) Limitedthis company | ₹480.65 Cr (FY 2023) | ₹5.01 Cr | 1% | 7.0% | 195 | New Delhi, Delhi, India |
| Amrutanjan Health Care Limited | ₹469.5 Cr (FY 2025) | 7.0% | Chennai, Tamil Nadu, India | |||
| SBL Private Limited | ₹395.16 Cr (FY 2025) | 1.0% | Haridwar, Uttarakhand, India |
To see the full peer comparison of Aimil Pharmaceuticals(India) Limited, buy the company report.
Auditor
Aimil Pharmaceuticals(India) Limited is audited by Ambani & Associates LLP for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Ambani & Associates LLP | FY 2023 | 016923N |
Shareholding
The shareholding of Aimil Pharmaceuticals(India) Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Aimil Pharmaceuticals(India) Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 08 Sep 2023 | 100822329 | Tata Capital Financial Services Limited | ₹1.75 Cr | Open | |
| 29 Oct 2021 | 100494397 | Others | ₹13.75 Cr | Open | |
| 08 Oct 2021 | 100508626 | Others | ₹34.75 Lakh | Open | |
| 14 Oct 2019 | 100299682 | Others | ₹83.51 Lakh | Open | |
| 04 Jan 2017 | 100075319 | Others | ₹15.9 Lakh | Open |
To see the full charge records of Aimil Pharmaceuticals(India) Limited, buy the company report.
Total charge records: 21 View all charges
Legal cases
Aimil Pharmaceuticals(India) Limited has 105 court cases on record: 53 filed by Aimil Pharmaceuticals(India), 52 filed against it. 20 cases are pending and 85 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 81 | 39 | 18 |
| High courts | 23 | 13 | 2 |
| Supreme Court | 1 | 0 | 0 |
Cases on record (5 of 105)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary Cases) | Filed against the company by Konark Herbals and Healthcare Private Limited Through Sanjay Manohar Gurav | Pending |
| District court, South West, Delhi | Cheque dishonour complaint | Filed against the company by Ocl Shipping India Pvt Ltd | Pending |
| District court, East, Delhi | Cheque dishonour complaint | Filed against the company by Maxcomm India Pvt Ltd | Disposed |
| District court, West, Delhi | Commercial suit | Filed by the company against Sanjay Baljiwan Ayurvedic Pharmacy Pvt. Ltd. | Disposed |
| District court, Central, Delhi | Commercial suit | Filed by the company against Akums Drugs and Pharmaceuticals Ltd and Anr and 1 other | Disposed |
To see the full case history of Aimil Pharmaceuticals(India) Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aimil Pharmaceuticals(India) Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Aimil Pharmaceuticals(India) Limited has a workforce of 195 employees on its EPFO records as of Jan 09, 2025, across 1 active EPFO establishment.
GST
Aimil Pharmaceuticals(India) has 24 GST registrations: 20 active and 4 cancelled or inactive. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAACA6166G1ZT | Delhi | Active | 01 Jul 2017 |
| 02AAACA6166G1Z3 | Himachal Pradesh | Active | 01 Jul 2017 |
| 03AAACA6166G1Z1 | Punjab | Active | 01 Jul 2017 |
| 06AAACA6166G1ZV | Haryana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Aimil Pharmaceuticals(India) Limited, buy the company report.
Recent activity
Aimil Pharmaceuticals(India) Limited has 10 board changes on record since 1984: 6 appointments and 4 cessations. The latest: Sanchit Sharma was appointed as Additional Director on 12 Feb 2025.
39 earlier events are in the company report.
Frequently asked questions
Aimil Pharmaceuticals(India) is an active public limited company based in New Delhi, Delhi, India. The company works in ayurvedic products and services, within the healthcare industry. It was incorporated on 30 November 1984 (42+ years old) and is registered under CIN U24231DL1984PLC019461.
Aimil Pharmaceuticals(India) has 6 current directors:
- Kanwal Kumar Sharma - Managing Director
- Ikshit Sharma - Director
- Sanchit Sharma - Additional Director
- Pankaj Marwaha - Director
- Satya Prakash Shrivastava - Director
- Manjula Sharma - Director
The latest financial statements of Aimil Pharmaceuticals(India) on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from 2015 are in the company report.
The GSTIN of Aimil Pharmaceuticals(India) is 07AAACA6166G1ZT, registered in Delhi. The company has 24 GST registrations in all, of which 20 are active and 4 are cancelled or inactive. Other active GSTINs include 02AAACA6166G1Z3 (Himachal Pradesh), 03AAACA6166G1Z1 (Punjab), 06AAACA6166G1ZV (Haryana).
The CIN (Corporate Identification Number) of Aimil Pharmaceuticals(India) is U24231DL1984PLC019461. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aimil Pharmaceuticals(India) has 105 court cases on record: 53 filed by the company and 52 filed against it. 20 are pending. Most are in the district courts.
Aimil Pharmaceuticals(India) was incorporated on 30 November 1984, making it 42+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Aimil Pharmaceuticals(India) by revenue are Siddhayu Ayurvedic Research Foundation Pvt Ltd, Natural Remedies Private Limited, Amrutanjan Health Care Limited, SBL Private Limited, all in the Healthcare industry (Ayurvedic Products and Services), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Sanchit Sharma was appointed as Additional Director on 12 Feb 2025. Ikshit Sharma ceased to be Additional Director on 31 Dec 2020. Ikshit Sharma was appointed as Director on 21 Nov 2019. Aimil Pharmaceuticals(India) has 10 board changes on record in total.
Aimil Pharmaceuticals(India) can be reached through the website aimilpharmaceuticals.com. Its registered office is in New Delhi, Delhi, India.
The registered office of Aimil Pharmaceuticals(India) is at 29944 Street No 17 Ranjeet Nagar, New Delhi, Delhi, India – 110008.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
